Clinical Impact of New Rheumatoid Arthritis Data from APLAR 2019, JCR 2019, and EULAR 2019*

Download All
APLAR 2019: Brisbane, Australia; April 8-11, 2019; JCR: Kyoto, Japan; April 15-17, 2019
EULAR: Madrid, Spain; June 12-15, 2019
Review the latest RA management data with Capsule Summaries, downloadable slides, and expert analysis covering key studies from APLAR 2019, JCR 2019, and EULAR 2019.
Leonard H. Calabrese, DO
Stanley B. Cohen, MD
Paul Emery, MA, MD, FRCP
Jonathan Kay, MD

Rheumatoid Arthritis

Slidesets EXTEND Open-Label Extension: Withdrawal of csDMARDs in Patients With Rheumatoid Arthritis Receiving Sarilumab
Slidesets Randomized Phase III Trial of IV Pegylated Liposomal Prednisolone vs IM Methylprednisolone for Rheumatoid Arthritis Flares
Slidesets FINCH 1: Phase III Trial of Filgotinib in Patients With Rheumatoid Arthritis With Inadequate Response to Methotrexate
Slidesets FINCH 3: Phase III Trial of Filgotinib ± Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis
Slidesets ORAL Shift: Withdrawal of Methotrexate in Patients With Rheumatoid Arthritis Who Achieved Low Disease Activity With Tofacitinib Plus Methotrexate
Slidesets SEMIRA: Tapering of Prednisone in Patients With Rheumatoid Arthritis Who Achieved Low Disease Activity or Remission With Tocilizumab
Slidesets Subcutaneous vs Intravenous Administration of CT-P13 for Rheumatoid Arthritis: Part 2 of Randomized Phase I/III Trial
Slidesets Long-Term Safety of Baricitinib in Patients with Rheumatoid Arthritis: Updated Findings from All-BARI-RA Analysis Set
Slidesets SELECT Pooled Analysis: Safety of Upadacitinib in Patients With Rheumatoid Arthritis
Slidesets SELECT-MONOTHERAPY Long-Term Extension: Phase III Trial of Upadacitinib in Patients With Rheumatoid Arthritis

Here’s how data from 2019 RA meetings will affect my practice.

Leonard H. Calabrese, DO Released: July 23, 2019

This expert-led CME-certified Conference Coverage provides a comprehensive review of key data on the management of RA from 2019 APLAR, EULAR, and JCR.

Stanley B. Cohen, MD Jonathan Kay, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: August 19, 2019 Expired: No longer available for credit

Download slide highlights of the top rheumatoid arthritis studies from these recent conferences.

Leonard H. Calabrese, DO Stanley B. Cohen, MD Paul Emery, MA, MD, FRCP Jonathan Kay, MD Released: July 3, 2019
Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences
Lilly
Sanofi Genzyme and Regeneron Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings